Literature DB >> 15774446

Facets and determinants of quality of life in patients with recurrent high grade glioma.

A R Giovagnoli1, A Silvani, E Colombo, A Boiardi.   

Abstract

OBJECTIVES: To assess patients with recurrent high grade brain glioma with the aim of evaluating facets of quality of life (QOL) and their association with mood, cognition, and physical performance.
METHODS: Ninety four glioma patients (four groups with different duration of glioma recurrence) were compared with 24 patients with other chronic neurological diseases and 48 healthy subjects. The Functional Living Index-Cancer (FLIC) provided QOL self evaluations, and standardised scales and neuropsychological tests assessed physical performance, mood, and cognition.
RESULTS: In glioma patients, factor analysis of the FLIC items documented five domains: Psychological well being, Role/sociability, Inner experience of disease, Isolation/sharing, and Nausea. Higher FLIC total scores were related to better cognition, physical performances, and mood, and lower grading; poorer Psychological well being and worse Inner experience of disease to depressed mood; minor Role/sociability to worse cognitive and physical performances and higher grading; worse Nausea to longer disease duration. Compared with healthy subjects, all glioma groups were cognitively impaired and more anxious, and two groups with short duration of recurrence were also more depressed. Patients with chronic neurological diseases showed worse mood and cognitive abilities compared with healthy subjects, but performed attention tests better than glioma patients. Glioma and chronic disease patients showed similar FLIC scores and autonomy.
CONCLUSIONS: These results show that QOL of recurrent high grade glioma patients is multifaceted and determined by multiple factors. Disease severity does not necessarily eliminate the possibility of expressing personal feelings and opinions which could provide criteria for clinical decision making and psychological support.

Entities:  

Mesh:

Year:  2005        PMID: 15774446      PMCID: PMC1739577          DOI: 10.1136/jnnp.2004.036186

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  35 in total

1.  Raven's coloured progressive matrices: normative values on 305 adult normal controls.

Authors:  A Basso; E Capitani; M Laiacona
Journal:  Funct Neurol       Date:  1987 Apr-Jun

2.  Progress in development of the index of ADL.

Authors:  S Katz; T D Downs; H R Cash; R C Grotz
Journal:  Gerontologist       Date:  1970

3.  Functional outcomes and quality of life in patients with brain tumors: a preliminary report.

Authors:  M E Huang; J E Wartella; J S Kreutzer
Journal:  Arch Phys Med Rehabil       Date:  2001-11       Impact factor: 3.966

4.  Quality of life in cancer patients--an hypothesis.

Authors:  K C Calman
Journal:  J Med Ethics       Date:  1984-09       Impact factor: 2.903

5.  Effect of disease burden on health-related quality of life in patients with malignant gliomas.

Authors:  D Osoba; M Brada; M D Prados; W K Yung
Journal:  Neuro Oncol       Date:  2000-10       Impact factor: 12.300

6.  Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.

Authors:  Guy Pelletier; Marja J Verhoef; Nasreen Khatri; Neil Hagen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

7.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

8.  Late cognitive and radiographic changes related to radiotherapy: initial prospective findings.

Authors:  C L Armstrong; J V Hunter; G E Ledakis; B Cohen; E M Tallent; B H Goldstein; Z Tochner; R Lustig; K D Judy; A Pruitt; J E Mollman; E M Stanczak; M Y Jo; T L Than; P Phillips
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

9.  Neuropsychological impairments associated with lesions caused by tumor or stroke.

Authors:  S W Anderson; H Damasio; D Tranel
Journal:  Arch Neurol       Date:  1990-04

Review 10.  A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma.

Authors:  J Dinnes; C Cave; S Huang; R Milne
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

View more
  50 in total

Review 1.  Systematic review of supportive care needs in patients with primary malignant brain tumors.

Authors:  Elizabeth Ford; Susan Catt; Anthony Chalmers; Lesley Fallowfield
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

Review 2.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

3.  Lexical access speed is significantly correlated with the return to professional activities after awake surgery for low-grade gliomas.

Authors:  Sylvie Moritz-Gasser; Guillaume Herbet; Igor Lima Maldonado; Hugues Duffau
Journal:  J Neurooncol       Date:  2012-01-24       Impact factor: 4.130

Review 4.  Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients.

Authors:  Dina Randazzo; Katherine B Peters
Journal:  CNS Oncol       Date:  2016-07-11

5.  [Supportive care and palliation in patients with malignant gliomas].

Authors:  Stefan Oberndorfer; Heinz Lahrmann
Journal:  Wien Med Wochenschr       Date:  2006-06

Review 6.  Awake surgery between art and science. Part I: clinical and operative settings.

Authors:  Andrea Talacchi; Barbara Santini; Francesca Casagrande; Franco Alessandrini; Giada Zoccatelli; Giovanna M Squintani
Journal:  Funct Neurol       Date:  2013 Jul-Sep

Review 7.  Life beyond a diagnosis of glioblastoma: a systematic review of the literature.

Authors:  L Gately; S A McLachlan; A Dowling; J Philip
Journal:  J Cancer Surviv       Date:  2017-02-13       Impact factor: 4.442

8.  Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.

Authors:  Jeffrey S Wefel; Timothy Cloughesy; James L Zazzali; Maoxia Zheng; Michael Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; James Vredenburgh; Asha Das; Henry S Friedman
Journal:  Neuro Oncol       Date:  2011-05-09       Impact factor: 12.300

9.  Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden.

Authors:  Daniel I Jacobs; Priya Kumthekar; Becky V Stell; Sean A Grimm; Alfred W Rademaker; Laurie Rice; James P Chandler; Kenji Muro; MaryAnne Marymont; Irene B Helenowski; Lynne I Wagner; Jeffrey J Raizer
Journal:  Neurooncol Pract       Date:  2014-05-05

10.  Interaction of quality of life, mood and depression of patients and their informal caregivers after surgical treatment of high-grade glioma: a prospective study.

Authors:  Maxi Sacher; Jürgen Meixensberger; Wolfgang Krupp
Journal:  J Neurooncol       Date:  2018-08-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.